Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Description of Inflammatory Cell Types in Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy (Xolair)

NCT00283504 is registered in ClinicalTrials.gov with Children's Hospital of The King's Daughters as lead sponsor.

NCT NCT00283504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00283504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Description of Inflammatory Cell Types in Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy (Xolair)
Lead sponsor
Children's Hospital of The King's Daughters
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2006
Completion date
January 31, 2009
Enrollment
13 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma